ICARS Strategy 2022 -2026

  29 August 2022

Since its inception in spring 2019, ICARS has bolted out of the starting blocks and achieved a great deal in its first years. These achievements were based on the strong strategic pillars that were developed in the early days to address the clear need, expressed by low- and middle-income countries, for tailored solutions to support National Action Plan implementation.

In this, our first official strategy, we draw on the lessons we have learnt, and project ourselves into the future. Guided by our vision of a world without drug-resistant infections, we have revised our outcome framework and refined the scope and goals of each of our interconnected pillars. In the following we are pleased to present a succinct overview of ICARS unique value proposition, followed by our overarching strategy that will run until 2026, as well as a roadmap that details our planned activities per pillar.

Download ICARS strategy to view on screen.

Further reading: ICARS
Author(s): ICARS
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed